Nature Communications (Jul 2020)

An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment

  • Corine H. GeurtsvanKessel,
  • Nisreen M. A. Okba,
  • Zsofia Igloi,
  • Susanne Bogers,
  • Carmen W. E. Embregts,
  • Brigitta M. Laksono,
  • Lonneke Leijten,
  • Casper Rokx,
  • Bart Rijnders,
  • Janette Rahamat-Langendoen,
  • Johannes P. C. van den Akker,
  • Jeroen J. A. van Kampen,
  • Annemiek A. van der Eijk,
  • Rob S. van Binnendijk,
  • Bart Haagmans,
  • Marion Koopmans

DOI
https://doi.org/10.1038/s41467-020-17317-y
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 5

Abstract

Read online

SARS-CoV-2 is causing a global pandemic in which the implementation of serology can support decision making in different scenarios. Here, the authors compare the outcome of eight commercially available assays to virus neutralization and discuss their use in diagnostics and exposure assessment of SARS-CoV-2.